跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Non-exclusive License) Technology Transfer Enterprise Selection Announcement - A Pair of Monoclonal Antibodies against the Nucleocapsid Protein of Infectious Bronchitis Virus
Date of Announcement
2020-09-16
 

Subject

(Non-exclusive License) Technology Transfer Enterprise Selection Announcement - A Pair of Monoclonal Antibodies against the Nucleocapsid Protein of Infectious Bronchitis Virus

Content

  • Technology:

A Pair of Monoclonal Antibodies against the Nucleocapsid Protein of Infectious Bronchitis Virus

  • Provider:

Associate Professor Hui-Wen Chen; Department/ Graduate Institute of Veterinary Medicine

  • Enterprise Eligibility

1. Industry Category: Biotechnology

2. Required Technical Know-how: Techniques of biomedical testing

3. Required Machinery and Equipment: Biomedical testing-related equipment

4. Required Research or Technical Staff: Personnel with backgrounds relevant to biomedicine

5. Other Requirements: No specific restrictions

 

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

  • How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

Contact Person

Winston Pan

TEL: +886-2-33669951

Email: lutepan@ntu.edu.tw

File download:
Technology Transfer Enterprise Selection Announcement - A Pair of Monoclonal Antibodies against the Nucleocapsid Protein of Infectious Bronchitis Virus
File size: 832kb